Geftiget 250mg Tablet

1. Product Introduction

Geftiget 250mg Tablet is a specialized anti-cancer medication containing Gefitinib as its active ingredient. Gefitinib belongs to a class of drugs known as tyrosine kinase inhibitors (TKIs). It is specifically designed to target and block certain proteins involved in the growth and spread of cancer cells. Geftiget 250mg is primarily prescribed for the treatment of non-small cell lung cancer (NSCLC), particularly in patients whose cancer cells have specific mutations in the epidermal growth factor receptor (EGFR) gene.

Manufactured under strict quality standards, Geftiget 250mg offers a trusted option for oncologists and cancer patients seeking targeted therapy. By interfering with the signaling pathways that promote cancer cell multiplication, this medicine slows down or even stops the progression of the disease. It is usually administered as a once-daily oral tablet, making it a convenient treatment option for patients.

2. Uses of Geftiget 250mg Tablet

• Non-Small Cell Lung Cancer (NSCLC):
  Geftiget 250mg is used as a first-line treatment for patients diagnosed with advanced or metastatic NSCLC, especially when tests reveal EGFR mutations. It helps in shrinking tumors and controlling disease progression.

• Maintenance Therapy:
  For patients who have responded to initial chemotherapy, Geftiget 250mg may be continued as maintenance therapy to prevent cancer from returning or worsening.

• Relapsed or Refractory NSCLC:
  Geftiget is also beneficial for patients whose cancer has relapsed after chemotherapy or who cannot tolerate traditional chemotherapy treatments.

3. Benefits of Geftiget 250mg Tablet

• Targeted Therapy:
  Unlike traditional chemotherapy, which affects both healthy and cancerous cells, Geftiget specifically targets cancer cells, minimizing damage to normal, healthy cells.

• Improved Quality of Life:
  Patients treated with Geftiget often experience better symptom control, including reduced breathing difficulties, less coughing, and improved energy levels.

• Convenient Oral Administration:
  Geftiget comes in tablet form and is taken orally once daily, allowing patients to continue their treatment at home without frequent hospital visits.

• Delays Disease Progression:
  Studies show that Gefitinib can significantly extend the time before the disease worsens, giving patients valuable months of improved life.

• Well-Tolerated:
  Compared to standard chemotherapy, Geftiget tends to have a more manageable side-effect profile, making it a preferred option for many patients.

4. Side Effects

Like all medications, Geftiget 250mg Tablet can cause side effects. Not everyone experiences them, and many side effects are mild or manageable. However, it’s important to be aware of possible reactions:

• Common Side Effects:

  • Skin rash

  • Diarrhea

  • Loss of appetite

  • Dry skin

  • Fatigue

  • Nausea and vomiting

• Serious Side Effects (Seek Medical Attention Immediately):

  • Severe lung problems (interstitial lung disease)

  • Liver enzyme abnormalities

  • Eye irritation or severe eye problems

  • Severe diarrhea leading to dehydration

• Rare Side Effects:

  • Gastrointestinal bleeding

  • Dehydration

  • Nail infections or changes

Note:
Patients should inform their doctor if side effects become bothersome or persist. Doctors may adjust the dosage or suggest supportive treatments to help manage side effects.

5. Frequently Asked Questions (FAQ)

Q1. How should I take Geftiget 250mg Tablet?
A1. Take Geftiget 250mg once daily, with or without food, as prescribed by your doctor. Swallow the tablet whole with a glass of water. Do not crush or chew the tablet.

Q2. What should I do if I miss a dose?
A2. If you miss a dose, take it as soon as you remember. If it is close to your next scheduled dose, skip the missed dose and resume your regular schedule. Do not take two doses at once.

Q3. How long do I need to take Geftiget 250mg Tablet?
A3. The duration of treatment depends on your cancer’s response and your doctor’s advice. Some patients may need long-term therapy, while others might stop if the disease progresses.

Q4. Can Geftiget 250mg be taken during pregnancy or breastfeeding?
A4. No, Geftiget is not recommended during pregnancy or breastfeeding. It may harm the unborn baby or pass into breast milk. Inform your doctor if you are pregnant, planning to become pregnant, or breastfeeding.

Q5. Are there any dietary restrictions while taking Geftiget 250mg?
A5. There are no strict dietary restrictions, but it is advisable to maintain a healthy diet. Avoid grapefruit and grapefruit juice as they may interfere with the medicine’s effectiveness.

References